European biotechnology company Actelion Ltd. (ALIOF) reported second quarter earnings of 78 cents per American Depository Receipt (ADR), down 23% over prior-year earnings of $1.01 per ADR and also below the Zacks Consensus Estimate of 90 cents. On a half yearly basis adjusted earnings were $1.77 per ADR, down 17% from $2.15 per ADR in [...]